<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Neurological <z:e sem="disease" ids="C0011119" disease_type="Disease or Syndrome" abbrv="">decompression sickness</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DCS</z:e>/AGE) may cover two variants with either severer and probably central <z:mp ids='MP_0008912'>nervous</z:mp> (Type A) or milder and sometimes doubtful neurological symptoms (Type B) </plain></SENT>
<SENT sid="1" pm="."><plain>The pathophysiology of the Type B-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DCS</z:e>/AGE might be different from the Type A-variant </plain></SENT>
<SENT sid="2" pm="."><plain>In Type A-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DCS</z:e>/AGE a higher <z:mp ids='MP_0004225'>PFO</z:mp>-prevalence (<z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo>) points towards an embolic origin of the Type A-symptomatology </plain></SENT>
<SENT sid="3" pm="."><plain>This is not necessarily expected for the Type B-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DCS</z:e>/AGE if the pathophysiology here is micro-embolic or even non-embolic </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: 18 patients with Type B-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DCS</z:e>/AGE were tested against matched controls for presence and size of a <z:mp ids='MP_0004225'>PFO</z:mp> with echocardiography and transcranial ultrasound with echo-contrast </plain></SENT>
<SENT sid="5" pm="."><plain>Prevalence and number of Type A-<z:e sem="disease" ids="C0221505" disease_type="Disease or Syndrome" abbrv="">brain lesions</z:e> were visualized by cranial MRI as possible sequelae from gas-embolic events </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:mp ids='MP_0004225'>PFO</z:mp>-prevalence in both groups, the patients with Type B-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DCS</z:e>/AGE (5/18) as well as the controls (7/18) was similar to published <z:mp ids='MP_0004225'>PFO</z:mp>-prevalences in <z:mpath ids='MPATH_458'>normals</z:mpath> without any difference between patients and controls (p = 0.725) </plain></SENT>
<SENT sid="7" pm="."><plain>Also the number of MRI-lesions (ACFs) was the same for Type B-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DCS</z:e>/AGE cases (15 ACFs in 5 patients) and controls (37 ACFs in 8 divers) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Indirect findings suggesting embolic brain injuries are found with similar frequency in patients with Type B-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DCS</z:e>/AGE and <z:mpath ids='MPATH_458'>normal</z:mpath> controls, which is in contrast to data about Type A-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DCS</z:e>/AGE </plain></SENT>
<SENT sid="9" pm="."><plain>This is compatible with different pathophysiological mechanisms involved in the Type A- and Type B-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DCS</z:e>/AGE </plain></SENT>
</text></document>